Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Guerriero JL"'
Publikováno v:
Journal of Burn Care & Research; 2008 Mar Supplement, Vol. 29 Issue 2, pS102-S102, 1p
Autor:
Timperi E; Santa Lucia Foundation IRCCS, 00143 Rome, Italy., Croizer H; Institute Curie, Paris, France., Khantakova D; Washington University in St. Louis, United States., Rana M; Institute Curie, France., Molgora M; Moffitt Cancer Center, Tampa, Florida, United States., Guerriero JL; Dana-Farber Cancer Institute, Boston, MA, United States., Mechta-Grigoriou F; Institute Curie, Paris, France., Romano E; Institute Curie, Paris, France.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 23. Date of Electronic Publication: 2024 Sep 23.
Autor:
Kapate N; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA, 02134, USA.; Wyss Institute for Biologically Inspired Engineering, Boston, MA, 02115, USA.; Harvard-MIT Program in Health Science and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Dunne M; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA, 02134, USA.; Wyss Institute for Biologically Inspired Engineering, Boston, MA, 02115, USA., Gottlieb AP; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA, 02134, USA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, 02115, USA., Mukherji M; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA, 02134, USA.; Wyss Institute for Biologically Inspired Engineering, Boston, MA, 02115, USA., Suja VC; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA, 02134, USA.; Wyss Institute for Biologically Inspired Engineering, Boston, MA, 02115, USA., Prakash S; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA, 02134, USA.; Wyss Institute for Biologically Inspired Engineering, Boston, MA, 02115, USA., Park KS; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA, 02134, USA.; Wyss Institute for Biologically Inspired Engineering, Boston, MA, 02115, USA., Kumbhojkar N; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA, 02134, USA.; Wyss Institute for Biologically Inspired Engineering, Boston, MA, 02115, USA., Guerriero JL; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, 02115, USA.; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA, 02215, USA., Mitragotri S; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA, 02134, USA.; Wyss Institute for Biologically Inspired Engineering, Boston, MA, 02115, USA.
Publikováno v:
Advanced healthcare materials [Adv Healthc Mater] 2024 Apr 06, pp. e2304144. Date of Electronic Publication: 2024 Apr 06.
Autor:
Baker GJ; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA.; Laboratory of Systems Pharmacology, Program in Therapeutic Science, Harvard Medical School, Boston, MA.; Department of Systems Biology, Harvard Medical School, Boston, MA., Novikov E; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA.; Laboratory of Systems Pharmacology, Program in Therapeutic Science, Harvard Medical School, Boston, MA.; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA., Zhao Z; Systems, Synthetic, and Quantitative Biology Program, Harvard University, Cambridge, MA., Vallius T; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA.; Laboratory of Systems Pharmacology, Program in Therapeutic Science, Harvard Medical School, Boston, MA., Davis JA; Breast Tumor Immunology Laboratory, Dana-Farber Cancer Institute, Boston, MA., Lin JR; Laboratory of Systems Pharmacology, Program in Therapeutic Science, Harvard Medical School, Boston, MA., Muhlich JL; Laboratory of Systems Pharmacology, Program in Therapeutic Science, Harvard Medical School, Boston, MA., Mittendorf EA; Breast Tumor Immunology Laboratory, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA., Santagata S; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA.; Laboratory of Systems Pharmacology, Program in Therapeutic Science, Harvard Medical School, Boston, MA.; Department of Systems Biology, Harvard Medical School, Boston, MA.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Guerriero JL; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA.; Laboratory of Systems Pharmacology, Program in Therapeutic Science, Harvard Medical School, Boston, MA.; Breast Tumor Immunology Laboratory, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA., Sorger PK; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA.; Laboratory of Systems Pharmacology, Program in Therapeutic Science, Harvard Medical School, Boston, MA.; Department of Systems Biology, Harvard Medical School, Boston, MA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Mar 22. Date of Electronic Publication: 2024 Mar 22.
Autor:
Goldberg J; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts., Qiao N; Department of Hematopoietic Biology & Malignancy, University of Texas MD Anderson Cancer Center, Houston, Texas., Guerriero JL; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Gross B; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts., Meneksedag Y; Faculty of Medicine, Hacettepe University, Ankara, Turkey., Lu YF; McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas., Philips AV; Department of Hematopoietic Biology & Malignancy, University of Texas MD Anderson Cancer Center, Houston, Texas., Rahman T; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts., Meric-Bernstam F; Department of Investigational Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Roszik J; Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, Texas., Chen K; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jeselsohn R; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tolaney SM; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Peoples GE; LumaBridge (formerly Cancer Insight), San Antonio, Texas., Alatrash G; Department of Hematopoietic Biology & Malignancy, University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Stem Cell Transplant and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas., Mittendorf EA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Feb 22; Vol. 4 (2), pp. 496-504.
Autor:
Michaud DE; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Cancer Institute, Boston, Massachusetts., Guerriero JL; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Cancer research [Cancer Res] 2024 Jan 16; Vol. 84 (2), pp. 181-183.
Autor:
Guerriero JL; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, 02115, USA. JGuerriero@bwh.harvard.edu.; Breast Tumor Immunology Laboratory, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. JGuerriero@bwh.harvard.edu.; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA, 02215, USA. JGuerriero@bwh.harvard.edu.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA, 02215, USA. JGuerriero@bwh.harvard.edu., Lin JR; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA, 02215, USA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA, 02215, USA., Pastorello RG; Breast Tumor Immunology Laboratory, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Pathology, Hospital Sírio Libanês, São Paulo, SP, 01308-050, Brazil., Du Z; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, Guangzhou, China., Chen YA; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA, 02215, USA., Townsend MG; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Breast Tumor Immunology Laboratory, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Shimada K; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Breast Tumor Immunology Laboratory, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA, 02215, USA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA, 02215, USA., Hughes ME; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, 02215, USA., Ren S; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Tayob N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Zheng K; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, 02115, USA., Mei S; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA, 02215, USA., Patterson A; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, 02215, USA., Taneja KL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Metzger O; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, 02215, USA., Tolaney SM; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, 02215, USA., Lin NU; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, 02215, USA., Dillon DA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Schnitt SJ; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Sorger PK; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA, 02215, USA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA, 02215, USA., Mittendorf EA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Breast Tumor Immunology Laboratory, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA, 02215, USA.; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, 02215, USA., Santagata S; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA, 02215, USA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA, 02215, USA.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Jan 02; Vol. 10 (1), pp. 2. Date of Electronic Publication: 2024 Jan 02.
Autor:
Patterson-Fortin J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Jadhav H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Pantelidou C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bayer Pharmaceuticals, Cambridge, MA, USA., Phan T; Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Grochala C; Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Arpeggio, Boulder, CO, USA., Mehta AK; Department of Surgical Oncology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.; Sanofi, Cambridge, MA, USA., Guerriero JL; Department of Surgical Oncology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA., Wulf GM; Department of Medicine, Division of Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Hale Family Center for Pancreatic Cancer Research, Dana-Farber Cancer Institute, Boston, MA, USA., Stanger BZ; Department of Medicine, Division of Gastroenterology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Hale Family Center for Pancreatic Cancer Research, Dana-Farber Cancer Institute, Boston, MA, USA., Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Hale Family Center for Pancreatic Cancer Research, Dana-Farber Cancer Institute, Boston, MA, USA., D'Andrea AD; Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA, USA., Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. geoffrey_shapiro@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. geoffrey_shapiro@dfci.harvard.edu.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA, USA. geoffrey_shapiro@dfci.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2023 Dec 11; Vol. 14 (1), pp. 8193. Date of Electronic Publication: 2023 Dec 11.
Autor:
Alečković M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Li Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Zhou N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard University, Cambridge, Massachusetts., Qiu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard University, Cambridge, Massachusetts., Lulseged B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Foidart P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Huang XY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Garza K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Shu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Kesten N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard University, Cambridge, Massachusetts., Li R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard University, Cambridge, Massachusetts., Lim K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard University, Cambridge, Massachusetts., Garrido-Castro AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Guerriero JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Surgery, Division of Breast Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Qi J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Long HW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard University, Cambridge, Massachusetts., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2023 Nov 01; Vol. 22 (11), pp. 1304-1318.
Autor:
Miller TE; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Department of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02215, USA.; Ludwig Center at Harvard Medical School, Boston, MA, USA., El Farran CA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Department of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02215, USA.; Ludwig Center at Harvard Medical School, Boston, MA, USA., Couturier CP; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Institute for Medical Engineering and Sciences and Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA 02115 USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA., Chen Z; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Department of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02215, USA., D'Antonio JP; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Department of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02215, USA., Verga J; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA., Villanueva MA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Institute for Medical Engineering and Sciences and Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Castro LNG; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute; Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115 USA., Tong YE; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Institute for Medical Engineering and Sciences and Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA., Saadi TA; Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec, Canada., Chiocca AN; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA., Fischer DS; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Heiland DH; Microenvironment and Immunology Research Laboratory, Medical Center - University of Freiburg, Freiburg, Germany. Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, USA., Guerriero JL; Ludwig Center at Harvard Medical School, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Cancer Institute; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Petrecca K; Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec, Canada., Suva ML; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Shalek AK; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Institute for Medical Engineering and Sciences and Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA., Bernstein BE; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Department of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02215, USA.; Ludwig Center at Harvard Medical School, Boston, MA, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Oct 27. Date of Electronic Publication: 2023 Oct 27.